Is the promise of more affordable weight loss drugs too good to be true? Compounded semaglutide, explained.
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Weight Loss Drug Super Bowl Ad Raises Questions About Compounded Vs. Branded Meds
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
BioSpace13h
After Lilly Powers Up Zepbound Supply, Analyst Wonders if Build-Out Is ‘Over Our Skis’
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Hosted on MSN13h
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
pharmaphorum15h
Will 2025 be the year the pharmaceutical industry finds its feet?
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
MCH to celebrate 200 successful open-heart surgeries in 2024
Medical Center Hospital is celebrating 200 successful open-heart surgeries in 2024. The Beat Goes On will take place from 4 p ...
Midland Memorial drive-thru testing update
The Midland Health Drive Thru Testing Clinic saw 30 patients Feb. 7 with a 26% positivity rate. The clinic will be testing Feb. 8 from 9 a.m. to 1 p.m. In addition, the clinic will be open next week ...